Are alternative strategies required to accelerate the global elimination of lymphatic filariasis? Insights from mathematical models
<p><strong>Background</strong> With the 2020 target year for elimination of lymphatic filariasis (LF) approaching, there is an urgent need to assess how long mass drug administration (MDA) programs with annual ivermectin + albendazole (IA) or diethylcarbamazine + albendazole (DA) w...
Main Authors: | Stolk, W, Prada, J, Smith, M, Kontoroupis, P, de Vos, A, Touloupou, P, Irvine, M, Brown, P, Subramanian, S, Kloek, M, Michael, E, Hollingsworth, T, de Vlas, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2018
|
Similar Items
-
Elimination or resurgence: modelling lymphatic filariasis after reaching the 1% microfilaremia prevalence threshold
by: Prada, JM, et al.
Published: (2019) -
Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination
by: Michael, E, et al.
Published: (2018) -
Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination.
by: Edwin Michael, et al.
Published: (2018-10-01) -
Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies
by: Prada, JM, et al.
Published: (2021) -
Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework.
by: Smith, M, et al.
Published: (2017)